Skip to content

US · BSTZ · ASSET MANAGEMENT

BlackRock Science and Technology Trust II (BSTZ) intrinsic value and stock valuation

$21.80as of 2026-11-21 · Mkt cap 2.06B

Data updated · price as of 2026-11-21

Fairly valuedIC value is within 20% of the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

BlackRock Science and Technology Trust II DCF and intrinsic value

InvestorsCraft values BSTZ with the Chepakovich two-stage DCF model — currently rated fairly valued. How the model works · Run your own DCF prefilled from BSTZ’s statements →

BlackRock Science and Technology Trust II Graham Number

Graham Number: $50.70d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Financial Services · Asset Management New York City, NY 10055 blackrock.com

How the business is doing

Fiscal 2019–2025, USD

Revenue
$266M+79.6% 5y CAGRd
20192025
Net income
$314.4M-9.6% 5y CAGRd
20192025
Free cash flow
-$-47.75M
20192025
Total equity
$1.72B+5.8% 5y CAGRd
20192025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2019–2025, USD
20252024202320222021
Revenue$266M$274.2M-$-34.32M$55.6M$151.9M
Operating income$314.8M$272.3M$280M-$-1.34B$136.1M
Net income$314.4M$272.3M$290.2M-$-654.77M$136M
EPSd$4.57M$7.86M$8.63M-$-20.29M$4.24M
Operating cash flow-$-47.75M$94.1M-$-34.35M$44.3M-$-30.9M
Capital expenditure$0.00$0.00$0.00$0.00$0.00
Free cash flow-$-47.75M$94.1M-$-34.35M$44.3M-$-30.9M
Total assets$1.75B$1.7B$1.66B$968.5M$1.71B
Total debt$17.5M$7.49M$3.21M$90K$0.00
Net debt$16.8M$7.09M$400K-$-10K-$-300K
Total equity$1.72B$1.67B$1.2B$960.7M$1.68B
Cash and short-term investments$30.4M$9.89M$6.71M$6.7M$43.7M
Income statement
20252024202320222021
Revenue$266M$274.2M-$-34.32M$55.6M$151.9M
Cost of revenue$20.6M$0.00$20.4M$12.7M$15.1M
Gross profit$245.4M$274.2M-$-54.76M$42.9M$136.7M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$0.00$750K$870K$1.15M$650K
Other expenses-$-69.41M$1.15M$1.38M$690K-$-560K
Operating expenses-$-69.41M$1.9M$2.24M$1.84M$90K
Cost and expenses-$-48.83M$1.9M-$-314.72M$710.3M$15.8M
Interest income$3.03M$0.00$0.00$0.00$0.00
Interest expense$0.00$0.00$10K$0.00$0.00
Depreciation and amortization$0.00$0.00$0.00$0.00$0.00
Ebitda$314.4M$272.3M$290.2M-$-654.7M$136.1M
Operating income$314.8M$272.3M$280M-$-1.34B$136.1M
Total other income/expenses, net-$-430K-$-270K-$-440K-$-260K-$-160K
Income before tax$314.4M$272.3M$280M-$-654.77M$136M
Income tax expense$0.00$0.00$0.00$0.00$0.00
Net income$314.4M$272.3M$290.2M-$-654.77M$136M
Weighted average shares outstanding$68.7M$34.6M$33.6M$32.3M$32.1M
Weighted average diluted shares outstanding$68.7M$34.6M$33.6M$32.3M$32.1M
Balance sheet
20252024202320222021
Cash and short-term investments$30.4M$9.89M$6.71M$6.7M$43.7M
Net receivables$1.56M$160K$2.09M$2.99M$10.3M
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$31.9M$9.91M$12.2M$8M$49.3M
Property, plant and equipment, net$0.00$0.00$0.00$0.00$0.00
Goodwill and intangible assets$0.00$0.00$0.00$0.00$0.00
Long-term investments$1.72B$1.69B$1.22B$1.51B$3.03B
Total non-current assets$1.72B$1.69B$1.65B$965.3M$3.03B
Total assets$1.75B$1.7B$1.66B$968.5M$1.71B
Accounts payable$14.1M$0.00$1.56M$1.13M$12.3M
Short-term debt$17.5M$7.49M$3.21M$0.00$0.00
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$17.5M$2.48M$3.21M$1.22M$12.3M
Long-term debt$0.00$0.00$350K$0.00$0.00
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$18.5M$13.4M$26.9M$16.5M$26.1M
Capital lease obligations$0.00$0.00$0.00$0.00$0.00
Total liabilities$36M$25.1M$27.9M$7.84M$26.1M
Common stock$942.7M$729.6M$778.6M$789.8M$795.2M
Retained earnings$774.4M$645.3M$417.8M$171M$886M
Accumulated other comprehensive income (loss)$0.00$0.00$417.8M$171M$886M
Total equity$1.72B$1.67B$1.2B$960.7M$1.68B
Total investments$1.75B$1.7B$1.22B$6.6M$3.08B
Total debt$17.5M$7.49M$3.21M$90K$0.00
Net debt$16.8M$7.09M$400K-$-10K-$-300K
Cash flow statement
20252024202320222021
Net income$314.4M$272.3M$290.2M-$-100.06M$136M
Depreciation and amortization$0.00$0.00$0.00$0.00$0.00
Stock-based compensation$0.00$0.00$0.00$0.00$0.00
Change in working capital-$-1.73M-$-4.59M$5.25M-$-1.89M$1.17M
Accounts receivable-$-30K$20K$230K-$-180K-$-70K
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$140K-$-460K$130K-$-410K$430K
Net cash provided by operating activities-$-47.75M$94.1M-$-42.77M$68.9M-$-103.11M
Investments in property, plant and equipment$0.00$0.00$0.00$0.00$0.00
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities$324.3M$323.5M$86.4M-$-11.41M$342.3M
Common stock issued$0.00$8.64M$41.6M$28.5M$14.6M
Common stock repurchased-$-74.45M$0.00$0.00$0.00$0.00
Dividends paid-$-153.4M-$-102.46M-$-96.62M-$-97.67M-$-120.21M
Net cash used for financing activities-$-256.13M-$-94.46M-$-175.85M-$-185.93M-$-225.09M
Net change in cash$330K-$-350K-$-1.62M-$-200K$170K
Cash at end of period$720K$140K$480K$100K$300K
Operating cash flow-$-47.75M$94.1M-$-34.35M$44.3M-$-30.9M
Capital expenditure$0.00$0.00$0.00$0.00$0.00
Free cash flow-$-47.75M$94.1M-$-34.35M$44.3M-$-30.9M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About BlackRock Science and Technology Trust II

        The BlackRock Science and Technology Term Trust is a closed-end equity mutual fund launched by BlackRock, Inc., and managed by BlackRock Advisors, LLC. This trust's mandate is to invest in publicly traded companies globally, with a specific focus on those operating within the science and technology sectors. Its investment approach primarily emphasizes growth stocks from firms of all market capitalizations. The fund was established in June 2019 and is based in the United States.

        CEO
        John M. Perlowski
        Employees
        0
        Beta
        1.47

        Explore

        Frequently asked questions

        What is the intrinsic value of BlackRock Science and Technology Trust II (BSTZ)?

        BlackRock Science and Technology Trust II (BSTZ) is currently fairly valued based on the InvestorsCraft IC model — IC value is within 20% of the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is BSTZ undervalued?

        BSTZ trades at a price of $21.80 (Nov 21, 2026): fairly valued — IC value is within 20% of the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.